Authors


Anusha Yeshokumar, MD

Latest:

Collaborating for Best Outcomes for Patients With Autoimmune Encephalitis

Autoimmune encephalitis is an unusual but important illness mental health care providers need to be aware of. Dr Deng and Dr Yeshokumar discuss.


Robert M. Kaplan, MBChB, FRANZCP, MA, MPhil

Latest:

Daniel M’Naghten: The Man Who Changed the Law on Insanity

"Despite many unanswered questions, Daniel M’Naghten is forever remembered as the man who set a lasting legal precedent."


Jonathan E. Alpert, MD, PhD

Latest:

Managing Suicidal Thoughts, Behaviors, and Risk in Treatment-Resistant Depression

A range of therapeutic targets are likely to be relevant for reducing risk of suicide in TRD. Here's what you need to know.


Benjamin I. Goldstein, MD, PhD

Latest:

Diagnostic and Treatment Challenges in Bipolar Disorder in Children and Adolescents

Just as the progress over recent decades has improved the clinical evaluation and management of BD among children and adolescents, the remaining gaps serve to inform future progress.


Boris Birmaher, MD

Latest:

Diagnostic and Treatment Challenges in Bipolar Disorder in Children and Adolescents

Just as the progress over recent decades has improved the clinical evaluation and management of BD among children and adolescents, the remaining gaps serve to inform future progress.


Eric A. Youngstrom, PhD

Latest:

Diagnostic and Treatment Challenges in Bipolar Disorder in Children and Adolescents

Just as the progress over recent decades has improved the clinical evaluation and management of BD among children and adolescents, the remaining gaps serve to inform future progress.


Mansoor Malik, MD

Latest:

Elder Abuse and Ageism During COVID-19

The pandemic hit everyone hard, but what implications and consequences has it had for the older generations?


Partam Manalai, MD

Latest:

Treatment Nonadherence: An Epidemic Hidden in Plain Sight

A number of factors affect treatment adherence, including the therapeutic alliance, perceived perceived lack of control, risk of dependence on medications, stigma associated with medication use, and more.


Jessica Lipschitz, MD

Latest:

Why You May Want to Swipe Left on Social Media

Based on recent data, it is looking more and more like the answer may be that social media is not particularly beneficial for most of us.


Nikhil Teja, MD

Latest:

Is There a Role for Saffron Phytotherapy in Treating Depression?

Patients often have questions concerning integrative therapeutic modalities, and it is important to know the existing evidence as well as limitations of current research.



Thomas J. Craig, MD, MPH

Latest:

A Critical Moment in Psychiatry: The Need for Meaningful Psychotherapy Training in Psychiatry

The goals of psychotherapy education in medical school should be based on these seven ideals.


Marshall Fitz, MD

Latest:

A Critical Moment in Psychiatry: The Need for Meaningful Psychotherapy Training in Psychiatry

The goals of psychotherapy education in medical school should be based on these seven ideals.


Ali Shana

Latest:

Mental Health Parity in the US: Have We Made Any Real Progress?

A breakdown of how we are living up to the ideals and standards proposed by the 2008 Mental Health Parity and Addiction Equity Act, including the pandemic's impact on parity.


Robert Schulman, MD

Latest:

If I Were an Astronomer

I would not want to simply map the stars; I would also want to gaze upon them and contemplate the mystery of it all. Such is the 15-minute med check versus the essence of psychiatry.


Obianuju O. Berry, MD, MPH

Latest:

Recognizing and Addressing Domestic Violence: Issues for Psychiatrists

A cultural shift has occurred and intimate partner violence (IPV) is no longer defined as a family affair, but one that has lasting effects on the individual, the family, and the community.


Catherine Monk, PhD

Latest:

Recognizing and Addressing Domestic Violence: Issues for Psychiatrists

A cultural shift has occurred and intimate partner violence (IPV) is no longer defined as a family affair, but one that has lasting effects on the individual, the family, and the community.


Junao Wang, MD

Latest:

Neuromodulation Approaches to Mood Disorders

As the evidence base grows and patients continue to demand better options, barriers will be lifted and neuromodulation will occupy a larger role in the psychiatric toolbox.


Alik S Widge, MD, PhD

Latest:

Neuromodulation Approaches to Depressive Disorders

In this CME article, review the principles and applications of both invasive and noninvasive neuromodulation techniques for the treatment of mood disorders.


Nathaniel Brooks III, MD, MSc

Latest:

A Clinician’s Brief Guide to Chronotherapy for Affective Disorders

Chronotherapy presents a unique tool to add to the armamentarium of available modalities for management of non-seasonal depression. Clinicians should be familiar with its application and be able to implement it in recalcitrant sufferers.


Allison E. Gaffey, PhD

Latest:

Stroke in Young Adults: The Lasting Effects of Trauma

This generation of young people may have a unique risk of exposure to stress and researchers and clinicians are increasingly concerned about the long-term health consequences of such chronic exposure for young adults.


Jason J. Sico, MD, MHS

Latest:

Stroke in Young Adults: The Lasting Effects of Trauma

This generation of young people may have a unique risk of exposure to stress and researchers and clinicians are increasingly concerned about the long-term health consequences of such chronic exposure for young adults.


Lindsey Rosman, PhD

Latest:

Stroke in Young Adults: The Lasting Effects of Trauma

This generation of young people may have a unique risk of exposure to stress and researchers and clinicians are increasingly concerned about the long-term health consequences of such chronic exposure for young adults.


Katherine Warburton, DO

Latest:

Pharmacological Management of Violence and Violent Behavior in Psychiatric Settings

Psychotic violence is associated with primary psychotic disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. While it may be that psychotic violence is the least common type of violence in inpatient environments, it is also the most treatable.


Michael A. Cummings, MD

Latest:

Pharmacological Management of Violence and Violent Behavior in Psychiatric Settings

Psychotic violence is associated with primary psychotic disorders such as schizophrenia, schizoaffective disorder, and bipolar disorder. While it may be that psychotic violence is the least common type of violence in inpatient environments, it is also the most treatable.


Dinah Miller, MD

Latest:

Violent Behavior and Involuntary Commitment: Ethical and Clinical Considerations

Ultimately, the decision about involuntary treatment is about risk, not predictable outcomes. In many cases, however, these decisions are much more difficult and, until our crystal balls arrive, our best efforts may still fall short.


Annette Hanson, MD

Latest:

“Terminal Anorexia”: An Invalid Construct That Does Not Justify Medical Aid in Dying

Does anorexia nervosa constitute an illness worthy of physician-assisted suicide? These authors think not.


Asim Shah, MD

Latest:

Breaking the Spell: Fighting Myths About COVID-19 Vaccination

The vaccine needs to be appropriately framed: as a benefit, not a risk.


Gregory Alexander Acampora, MD

Latest:

Special Issues for Patients With SUDs Undergoing Surgery

This innovative program at Massachusetts General Hospital addresses postoperative pain while preventing relapse in patients a history of opioid use disorder.


Andrea Amerio, MD, PhD

Latest:

Untangling the Web of Comorbid Obsessive-Compulsive Disorder and Medical Illness

OCD symptoms can be quite difficult to recognize. Not understanding what is happening, patients tend to be ashamed and suffer in silence, often resulting in a period of 8 to 10 years of untreated illness and long-term negative outcomes.

© 2024 MJH Life Sciences

All rights reserved.